New Series of Fluoroquinolone Analogues as Potential Anticancer Agents: Design, Synthesis, In Vitro Biological Evaluation, and Topoisomerase II Inhibition

Nermeen Ali; Mina Adly; Azza T. Taher; H. M. Coleman; Fakher Ahmed; Ashraf Mahmoud; Mohamed Salem; Rana El-Masry

New Series of Fluoroquinolone Analogues as Potential Anticancer Agents: Design, Synthesis, In Vitro Biological Evaluation, and Topoisomerase II Inhibition

Nermeen Ali, Mina Adly, Azza T. Taher, H. M. Coleman, Fakher Ahmed, Ashraf Mahmoud, Mohamed Salem, Rana El-Masry

Research output: Contribution to conference › Poster

Abstract

Poster presentation

Original language	English
Publication status	Unpublished - 2 Oct 2024
Event	Drug Discovery 2024 - ExCel, London, London, United Kingdom Duration: 2 Oct 2024 → 3 Oct 2024 https://elrig.org/portfolio/drug-discovery-2024/

Conference

Conference	Drug Discovery 2024
Country/Territory	United Kingdom
City	London
Period	2/10/24 → 3/10/24
Internet address	https://elrig.org/portfolio/drug-discovery-2024/

Cite this

@conference{9b83122ab75d4c67bab1c01551b685d6,

title = "New Series of Fluoroquinolone Analogues as Potential Anticancer Agents: Design, Synthesis, In Vitro Biological Evaluation, and Topoisomerase II Inhibition",

abstract = "Poster presentation",

author = "Nermeen Ali and Mina Adly and Taher, \{Azza T.\} and Coleman, \{H. M.\} and Fakher Ahmed and Ashraf Mahmoud and Mohamed Salem and Rana El-Masry",

year = "2024",

month = oct,

day = "2",

language = "English",

note = "Drug Discovery 2024 ; Conference date: 02-10-2024 Through 03-10-2024",

url = "https://elrig.org/portfolio/drug-discovery-2024/",

}

TY - CONF

T1 - New Series of Fluoroquinolone Analogues as Potential Anticancer Agents: Design, Synthesis, In Vitro Biological Evaluation, and Topoisomerase II Inhibition

AU - Ali, Nermeen

AU - Adly, Mina

AU - Taher, Azza T.

AU - Coleman, H. M.

AU - Ahmed, Fakher

AU - Mahmoud, Ashraf

AU - Salem, Mohamed

AU - El-Masry, Rana

PY - 2024/10/2

Y1 - 2024/10/2

N2 - Poster presentation

AB - Poster presentation

M3 - Poster

T2 - Drug Discovery 2024

Y2 - 2 October 2024 through 3 October 2024

ER -

New Series of Fluoroquinolone Analogues as Potential Anticancer Agents: Design, Synthesis, In Vitro Biological Evaluation, and Topoisomerase II Inhibition

Abstract

Conference

Fingerprint

Cite this